These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 33796258)

  • 1. Translating evidence into practice during the COVID-19 pandemic: pitfalls and mileages.
    Mangoni AA; Erre GL
    Ther Adv Drug Saf; 2021; 12():2042098621998876. PubMed ID: 33796258
    [No Abstract]   [Full Text] [Related]  

  • 2. Machine Learning Applications in Drug Repurposing.
    Yang F; Zhang Q; Ji X; Zhang Y; Li W; Peng S; Xue F
    Interdiscip Sci; 2022 Mar; 14(1):15-21. PubMed ID: 35066811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A New Approach to Drug Repurposing with Two-Stage Prediction, Machine Learning, and Unsupervised Clustering of Gene Expression.
    Cong Y; Shintani M; Imanari F; Osada N; Endo T
    OMICS; 2022 Jun; 26(6):339-347. PubMed ID: 35666246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SperoPredictor: An Integrated Machine Learning and Molecular Docking-Based Drug Repurposing Framework With Use Case of COVID-19.
    Ahmed F; Lee JW; Samantasinghar A; Kim YS; Kim KH; Kang IS; Memon FH; Lim JH; Choi KH
    Front Public Health; 2022; 10():902123. PubMed ID: 35784208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug Repurposing During The COVID-19 Pandemic: Lessons For Expediting Drug Development And Access.
    Greenblatt W; Gupta C; Kao J
    Health Aff (Millwood); 2023 Mar; 42(3):424-432. PubMed ID: 36877896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-Omics and Artificial Intelligence-Guided Drug Repositioning: Prospects, Challenges, and Lessons Learned from COVID-19.
    Cong Y; Endo T
    OMICS; 2022 Jul; 26(7):361-371. PubMed ID: 35759424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug repurposing for COVID-19: Approaches, challenges and promising candidates.
    Ng YL; Salim CK; Chu JJH
    Pharmacol Ther; 2021 Dec; 228():107930. PubMed ID: 34174275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization and quantification of PM
    Lin YC; Li YC; Amesho KTT; Chou FC; Cheng PC
    Sci Total Environ; 2019 Apr; 660():188-198. PubMed ID: 30640087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral pandemic preparedness: A pluripotent stem cell-based machine-learning platform for simulating SARS-CoV-2 infection to enable drug discovery and repurposing.
    Esmail S; Danter W
    Stem Cells Transl Med; 2021 Feb; 10(2):239-250. PubMed ID: 32961040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comprehensive review of artificial intelligence and network based approaches to drug repurposing in Covid-19.
    Ahmed F; Soomro AM; Chethikkattuveli Salih AR; Samantasinghar A; Asif A; Kang IS; Choi KH
    Biomed Pharmacother; 2022 Sep; 153():113350. PubMed ID: 35777222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate.
    Delijewski M; Haneczok J
    Med Drug Discov; 2021 Mar; 9():100077. PubMed ID: 33521623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Artificial Intelligence in COVID-19 drug repurposing.
    Mohanty S; Harun Ai Rashid M; Mridul M; Mohanty C; Swayamsiddha S
    Diabetes Metab Syndr; 2020; 14(5):1027-1031. PubMed ID: 32634717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays.
    Wang X; Guan Y
    Med Res Rev; 2021 Jan; 41(1):5-28. PubMed ID: 32864815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can drug repurposing strategies be the solution to the COVID-19 crisis?
    Bellera CL; Llanos M; Gantner ME; Rodriguez S; Gavernet L; Comini M; Talevi A
    Expert Opin Drug Discov; 2021 Jun; 16(6):605-612. PubMed ID: 33345645
    [No Abstract]   [Full Text] [Related]  

  • 15. Fighting COVID-19 with Artificial Intelligence.
    Monteleone S; Kellici TF; Southey M; Bodkin MJ; Heifetz A
    Methods Mol Biol; 2022; 2390():103-112. PubMed ID: 34731465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19.
    Assmus F; Driouich JS; Abdelnabi R; Vangeel L; Touret F; Adehin A; Chotsiri P; Cochin M; Foo CS; Jochmans D; Kim S; Luciani L; Moureau G; Park S; Pétit PR; Shum D; Wattanakul T; Weynand B; Fraisse L; Ioset JR; Mowbray CE; Owen A; Hoglund RM; Tarning J; Lamballerie X; Nougairède A; Neyts J; Sjö P; Escudié F; Scandale I; Chatelain E
    Microorganisms; 2022 Aug; 10(8):. PubMed ID: 36014057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Staying Ahead of the Game: How SARS-CoV-2 has Accelerated the Application of Machine Learning in Pandemic Management.
    Williams AH; Zhan CG
    BioDrugs; 2023 Sep; 37(5):649-674. PubMed ID: 37464099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug repurposing against coronavirus disease 2019 (COVID-19): A review.
    Luo L; Qiu Q; Huang F; Liu K; Lan Y; Li X; Huang Y; Cui L; Luo H
    J Pharm Anal; 2021 Dec; 11(6):683-690. PubMed ID: 34513115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the COVID-19 Pandemic on Clinical Trial Discontinuation in Anesthesiology: Cross-sectional Analysis.
    Traxler BD; Rucker BM; Greenough MC; Sajjadi NB; Hartwell M
    JMIR Perioper Med; 2022 Apr; 5(1):e34936. PubMed ID: 35358057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging role of artificial intelligence in therapeutics for COVID-19: a systematic review.
    Kaushal K; Sarma P; Rana SV; Medhi B; Naithani M
    J Biomol Struct Dyn; 2022 Jul; 40(10):4750-4765. PubMed ID: 33300456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.